Project Grant T32AI187009
Award Date 6/15/26
Completion Date 5/31/31
Dollars Obligated $192K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $596,318 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 10, 2026, through January 31, 2031. The award supports research investigating virulence factor functions in non-typhoidal Salmonella typhimurium pathogenesis, specifically examining how bacterial effector proteins...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $415,000 Project Grant to The University of Texas Southwestern Medical Center on May 7, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The five-year project, scheduled for completion by April 30, 2031, delivers investigator-initiated biomedical research aimed at establishing mechanistic insights into a novel cell cycle regulator complex for cancer therapy...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $828,340 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 6, 2026, with a completion date of January 31, 2031. The award supports investigator-initiated biomedical research focused on understanding HIV-1 transcription reactivation mechanisms in latently infected reservoir cells....
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $451,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025, through June 30, 2027. This award supports the development and utilization of a humanized lung-on-a-chip model to investigate nontuberculous mycobacteria (NTM) infections in a physiologically relevant...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $498,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 7, 2025 through July 31, 2030. This award funds research investigating the role of fungal stimulatory RNA (FSRNA) in modulating intestinal innate immune responses and inflammation. The project employs...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a Project Grant award of $436,466 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 2, 2025, with a completion date of June 30, 2027. This exploratory research grant supports investigator-initiated biomedical research focused on understanding the regulatory mechanisms of the FOXN1 gene and...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $149,035 Project Grant to The University of Texas Southwestern Medical Center (UT Southwestern) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on May 6, 2026, with a completion date of April 30, 2028. This award supports investigator-initiated biomedical research examining glycosylation as a host defense mechanism against alphaviruses, specifically focusing on how the...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $456,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 2, 2026, through January 31, 2028. This research initiative investigates the oligoadenylate synthetase (OAS)-RNase L pathway's role in intestinal immunity and inflammatory bowel disease. The project delivers two...
- Federal Project Grant Award Summary The University of Texas Medical Branch at Galveston received a $444,125 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 12, 2026, with a completion date of May 31, 2028. The award funds investigator-initiated biomedical research examining the role of long non-coding ribonucleic acids (lncRNAs) in modulating host immunity and...
- Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Texas Southwestern Medical Center a $3.28 million Project Grant on August 21, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The four-year research initiative, scheduled for completion on July 31, 2029, focuses on elucidating the mechanisms by which host ubiquitin ligases and deubiquitinases regulate immune responses against Mycobacterium tuberculosis...